In-stent @entity715 and @entity850 after neck-remodeling device-assisted coil embolization of XXXX .

@entity1 @entity439 @entity715 @entity850 @entity438
BACKGROUND: Intrinsic @entity715 and @entity850 are complications associated with the use of neck-remodeling devices in the treatment of @entity438 . OBJECTIVE: To examine the technical and anatomic factors that predict short- and long-term stent patency. METHODS: We undertook a retrospective review of 161 @entity1 who underwent coil embolization of 168 ruptured and @entity439 assisted by the use of a neck-remodeling device. One hundred twenty-seven @entity1 had catheter-based angiographic follow-up to evaluate 133 stent-coil constructs (mean, 15.4 months; median, 12.7 months). The technique of microcatheter jailing was used in a majority of @entity1 ; nonstandard stent configurations were also used. RESULTS: Clinical follow-up for all @entity1 who had catheter-based angiograms demonstrated that among 133 stent constructs, a total of 9 (6.8%) had an in-stent event: 6 acute or subacute @entity715 (4.5%) and 3 delayed @entity850 or occlusion (2.3%). Seven of these constructs were associated with a symptomatic event (5.3%). A significantly higher rate of in-stent events was seen with the use of constructs to treat anterior communicating @entity438 . When all @entity1 are considered, including those who did not receive catheter-based follow-up imaging, 2 of 168 procedures (1.2%) resulted in the death of a @entity1 , and procedural morbidity was 14.9%. CONCLUSION: From these results and those in the published literature, in-stent complication rates are low in carefully selected @entity1 . The use of dual antiplatelet therapy, sensitivity assays, and glycoprotein IIb/IIIa inhibitors may decrease the rate of acute and chronic in-stent complications.
